ktsimage / iStockphoto.com
The Federal Court of Justice, Germany’s Supreme Court, has upheld a lower court’s ruling that granted a preliminary compulsory licence to use a patent protecting an HIV treatment.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
German Federal Court of Justice, German Federal Patent Court, HIV, compulsory licence, patent, Merck & Co, Shionogi, raltegravir, European Patent Office